CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells
{{output}}
Microtubule targeting agents (MTAs) are extensively used in cancer treatment and many have achieved substantial clinical success. In recent years, targeting microtubules to inhibit cell division has become a widespread pharmaceutical approach for treatment of ... ...